ResearcherUniversity of Southern CaliforniaActive in the last 2 years

Ani Misirian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-5902-3041; OpenAlex author ID A5099337870. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond. Co-author DOI 10.1177/17588359261432058 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Diana L. Hanna · 1 shared paper, 2026 · strength 0.50
- Paper Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond. DOI 10.1177/17588359261432058 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.